Registration

GREENWICH BIOSCIENCES, INC. for GREENWICH BIOSCIENCES, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Pharmaceutical manufacturing and Healthcare

LobbyistCovered position, as disclosed
ALICE P. MEAD New Vice President, U.S. Professional Relations

Health Issues HCR

Pharmaceutical manufacturing and Healthcare

LobbyistCovered position, as disclosed
ALICE P. MEAD New Vice President, U.S. Professional Relations

Medicare/Medicaid MMM

Pharmaceutical manufacturing and Healthcare

LobbyistCovered position, as disclosed
ALICE P. MEAD New Vice President, U.S. Professional Relations

Insurance INS

Pharmaceutical manufacturing and Healthcare

LobbyistCovered position, as disclosed
ALICE P. MEAD New Vice President, U.S. Professional Relations

Pharmacy PHA

Pharmaceutical manufacturing and Healthcare

LobbyistCovered position, as disclosed
ALICE P. MEAD New Vice President, U.S. Professional Relations

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
GW PHARMACEUTICALS PLC United Kingdom United Kingdom 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.